David Eldar

CFO

Eyal Lifschitz

General Partner and Co-Founder

Boaz Lifschitz

General Partner and Co - Founder

82 past transactions

Cordio Medical

Venture Round in 2022
Cordio Medical offers to create and deliver game-changing solutions for monitoring health conditions using a patient's voice. They offer transcription of a patient free speech into a smartphone app. They assist physicians in preventing patient deterioration and hospitalization while keeping the patient at home by assisting them in identifying and mitigating condition worsening.

Bluewhite

Series B in 2021
Blue White Robotics revolutionizes agriculture through autonomy. We provide a complete infrastructure for autonomy and in-field data for improving productivity and farm economics. Our platform transforms existing fleets into autonomous, manages, and optimizes them both air & ground while collecting and distributing data seamlessly. We improve efficiency, and safety and provide actionable insights that drive ROI from the first day. Leveraging remote sensing and AI, we are setting the highest standard for easy and safe adoption of autonomy in agriculture today. Autonomy, Now.

BrainQ

Venture Round in 2021
BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach. The company was founded in 2016 and is headquartered in Jerusalem, Yerushalayim, Israel.

Aleph Farms

Series B in 2021
Aleph Farms is an Israel-based food technology company designing new ways to grow quality animal products that improve sustainability, food security and animal welfare in our food systems. Founded in 2017, the company utilized cellular agriculture technology to unveil the world’s first cultivated thin-cut steak in 2018, the world’s first cultivated ribeye steak in 2021, and cultivated collagen in 2022. Under its product brand, Aleph Cuts, the company will launch its first product, the Petit Steak, grown from the non-modified cells of a premium Angus cow. For its contributions to climate leadership including a net zero commitment made in 2020, it has received top accolades from the World Economic Forum and the United Nations.

Aleph Farms

Series B in 2021
Aleph Farms is an Israel-based food technology company designing new ways to grow quality animal products that improve sustainability, food security and animal welfare in our food systems. Founded in 2017, the company utilized cellular agriculture technology to unveil the world’s first cultivated thin-cut steak in 2018, the world’s first cultivated ribeye steak in 2021, and cultivated collagen in 2022. Under its product brand, Aleph Cuts, the company will launch its first product, the Petit Steak, grown from the non-modified cells of a premium Angus cow. For its contributions to climate leadership including a net zero commitment made in 2020, it has received top accolades from the World Economic Forum and the United Nations.

KAHR medical

Venture Round in 2021
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment options for cancer and autoimmune disorders.

Ribon Therapeutics

Series C in 2021
Ribon Therapeutics is a biotechnology company pioneering the discovery of new cancer medicines that target monoPARP proteins, critical regulators of cancer survival mechanisms. The diverse and central functions that PARPs, or poly(ADP-ribose) polymerases, play in cancer cell survival pathways are just emerging, and many of the seminal discoveries in the field have been made by Ribon’s scientific founders. By combining insights from our founders and an experienced management team, Ribon is building a proprietary drug discovery platform to investigate the molecular action and biological function of a subset of the PARP protein family, called monoPARPs. Based on its platform, Ribon is creating a pipeline of innovative medicines that selectively target monoPARPs to treat cancer and may have the potential to impact other diseases. The company is backed by prominent life science investors, including The Column Group, U.S. Venture Partners, Deerfield Management and Osage University Partners.

Memic Innovative Surgery

Series D in 2021
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

OutSense

Series A in 2020
OutSensedevelops an IOT sensor for early detection of illness and as wellness monitoring tool. A medical status report for each person is generated daily in the form of our biological excretions. OutSense is using innovative imaging technologies to reveal this information. The sensor will monitor essential health and wellness parameters and communicate them with a mobile device app. The primary goal is to prevent colorectal cancer by identifying hidden blood in stool. Hidden blood is a well-established screening tool for colorectal cancer (CRC), currently performed by sending a stool sample to a specialized lab.

BioProtect

Series D in 2020
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.

Bluewhite

Series A in 2020
Blue White Robotics revolutionizes agriculture through autonomy. We provide a complete infrastructure for autonomy and in-field data for improving productivity and farm economics. Our platform transforms existing fleets into autonomous, manages, and optimizes them both air & ground while collecting and distributing data seamlessly. We improve efficiency, and safety and provide actionable insights that drive ROI from the first day. Leveraging remote sensing and AI, we are setting the highest standard for easy and safe adoption of autonomy in agriculture today. Autonomy, Now.

Artfix

Series A in 2020
Atrial Fibrillation treatment using cryo

Hairstetics

Convertible Note in 2020
Hairstetics is an innovative medical device company. They provide surgical hair transplantation, non-surgical hair loss solutions, and hair implantation services. They also offer hair implant options colors, styles, and lengths.

Endomatic

Series A in 2020
Catheter procedure for LAA (left atrial appendage) closure, for Atrial fibrillation patients

Levation Pharma

Venture Round in 2020
Aesthetic dermatology

Payzday

Series B in 2020
Deploying the latest technologies Payzday is able to create unprecedented visibility into the risk level of merchants selling on marketplaces. Payzday goes much further than analyzing and predicting merchant behavior during the onboarding process analyzing past data. Payzday provides continuous monitoring to predict in near real time any unlawful, risky, or unstable situation of the Merchant.

SinuSafe Medical

Convertible Note in 2020
SinuSafe Medical develops a nano-debrider device for sinuses irrigating and aspirating without surgical intervention. The device implants bone between the lining and maxillary sinus in the upper jaw, allowing patients to get rid of sinus problems. SinuSafe Medical was founded in 2014 and is headquartered in Tel Aviv, Israel.

Restore Medical

Series A in 2020
Restore Medical develops and provides a device-based therapy for congestive heart failure. It improves patient quality of life and reduce hospital readmission rates. Restore Medical's product, ContraBand, is a novel catheter-delivered implant in the pulmonary arteries for treatment of left ventricle failure, for patients with preserved right ventricle function. Restore Medical was founded in 2016 and is headquartered in Or Yehuda, Israel.

Raziel Health

Series C in 2019
Raziel Health is focused on developing innovative treatments for obesity and fat disorders, particularly through its injectable drug RZL-012. This novel synthetic small molecule is designed to be injected directly into fat tissue, where it induces fat cell death, leading to a reduction in fat at the injection site. The company, founded in 2012 and based in Rehovot, Israel, aims to provide accessible and cost-effective healthcare solutions that enhance patient experience and promote timely clinical interventions. By integrating user-friendly technologies and leveraging data analytics, Raziel Health supports wellness and disease management, ensuring that individual patient goals are met effectively.

Raziel Health

Series C in 2019
Raziel Health is focused on developing innovative treatments for obesity and fat disorders, particularly through its injectable drug RZL-012. This novel synthetic small molecule is designed to be injected directly into fat tissue, where it induces fat cell death, leading to a reduction in fat at the injection site. The company, founded in 2012 and based in Rehovot, Israel, aims to provide accessible and cost-effective healthcare solutions that enhance patient experience and promote timely clinical interventions. By integrating user-friendly technologies and leveraging data analytics, Raziel Health supports wellness and disease management, ensuring that individual patient goals are met effectively.

Magneto Thrombectomy

Series A in 2019
Medical device for clot retrival

BioRefine

Seed Round in 2019
Medical device company treating the mitral valve

Roby.AI

Series A in 2019
Roby offers an artificial intelligence assistant for rental agencies and property managers. It an autonomous machine that requires only a few human interventions and is able to execute across all the different tasks involved in property management. Roby utilizes push notifications via SMS and email to invite users and their clients to engage with the rental process. It reduces manual tasks, streamlines workflow, improves compliance, and reduces costs.

Aleph Farms

Series A in 2019
Aleph Farms is an Israel-based food technology company designing new ways to grow quality animal products that improve sustainability, food security and animal welfare in our food systems. Founded in 2017, the company utilized cellular agriculture technology to unveil the world’s first cultivated thin-cut steak in 2018, the world’s first cultivated ribeye steak in 2021, and cultivated collagen in 2022. Under its product brand, Aleph Cuts, the company will launch its first product, the Petit Steak, grown from the non-modified cells of a premium Angus cow. For its contributions to climate leadership including a net zero commitment made in 2020, it has received top accolades from the World Economic Forum and the United Nations.

mPharma

Series B in 2019
mPharma Data, Inc. is a technology-driven company based in Accra, Ghana, with an additional location in Lexington, Massachusetts. Founded in 2013, it focuses on improving access to high-quality medications in emerging markets by connecting physicians, pharmacies, and patients through its application. The company aggregates real-time market data on prescription trends, drug consumption, and adverse reactions, providing valuable insights to pharmaceutical manufacturers, distributors, and governments. mPharma offers a pharmacy network application that centralizes inventories from multiple pharmacies, enabling easier drug searches for physicians and patients. Additionally, the company provides subscription-based data analytics for actionable insights on drug consumption and diagnosis, along with prescription management tools to assist healthcare providers in locating various medicines. By partnering with drug manufacturers, insurance companies, and governments, mPharma aims to facilitate affordable access to essential medications for patients.

Endomatic

Series A in 2018
Catheter procedure for LAA (left atrial appendage) closure, for Atrial fibrillation patients

Heracure Medical

Seed Round in 2018
Selective mechanical resection of fibroids, via natural orifice access/transvaginal.

Payzday

Seed Round in 2018
Deploying the latest technologies Payzday is able to create unprecedented visibility into the risk level of merchants selling on marketplaces. Payzday goes much further than analyzing and predicting merchant behavior during the onboarding process analyzing past data. Payzday provides continuous monitoring to predict in near real time any unlawful, risky, or unstable situation of the Merchant.

Kymera Labs

Seed Round in 2018
Kymera Labs offers devised a novel mathematical method for data synthesis that is based on a patent. With the help of our synthetic data generator, synthetic data may be enhanced and tailored to various data verticals while keeping the highest levels of accuracy and adherence to privacy laws.

Magneto Thrombectomy

Series A in 2018
Medical device for clot retrival

Artfix

Seed Round in 2018
Atrial Fibrillation treatment using cryo

Restore Medical Solutions

Series A in 2018
Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

Memic Innovative Surgery

Series C in 2018
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Hairstetics

Seed Round in 2018
Hairstetics is an innovative medical device company. They provide surgical hair transplantation, non-surgical hair loss solutions, and hair implantation services. They also offer hair implant options colors, styles, and lengths.

CliClap

Series A in 2018
CliClap is a smart, hands-off inbound lead generation and qualification solution for your content marketing channels. Artificial intelligence now has the power to generate more engaged prospects and more nurtured, qualified leads... with no management. CliClap’s AI-powered solution leads each visitor through a personalized, goal-oriented content journey, providing him with the precise piece of content needed to move him forward in your sales funnel - at the perfect time. CliClap harnessed and packaged the power of AI for your marketing team to become more efficient, increasing conversion rates by at least 150%. CliClap integrates with your existing marketing automation, CRM, content, social media management, and other tools and empowers them to work smarter.

CliClap

Seed Round in 2018
CliClap is a smart, hands-off inbound lead generation and qualification solution for your content marketing channels. Artificial intelligence now has the power to generate more engaged prospects and more nurtured, qualified leads... with no management. CliClap’s AI-powered solution leads each visitor through a personalized, goal-oriented content journey, providing him with the precise piece of content needed to move him forward in your sales funnel - at the perfect time. CliClap harnessed and packaged the power of AI for your marketing team to become more efficient, increasing conversion rates by at least 150%. CliClap integrates with your existing marketing automation, CRM, content, social media management, and other tools and empowers them to work smarter.

Levation Pharma

Seed Round in 2018
Aesthetic dermatology

DOKKA

Pre Seed Round in 2018
The Future of Accounting Automation. DOKKA automates your entire invoice processing workflow using proprietary technology, eliminating bottlenecks and liberating you from repetitive, manual work. Seamlessly Integrated With Your Accounting System. Whether you’re using a well-known ERP or a lesser known accounting system, DOKKA integrates into any tech stack. Directly integrated (2-way) with all major accounting ERP platforms. Done-for-you and done-with-you API integrations. Deploys in just 7-14 days.

Payzday

Seed Round in 2017
Deploying the latest technologies Payzday is able to create unprecedented visibility into the risk level of merchants selling on marketplaces. Payzday goes much further than analyzing and predicting merchant behavior during the onboarding process analyzing past data. Payzday provides continuous monitoring to predict in near real time any unlawful, risky, or unstable situation of the Merchant.

Cordio Medical

Series B in 2017
Cordio Medical offers to create and deliver game-changing solutions for monitoring health conditions using a patient's voice. They offer transcription of a patient free speech into a smartphone app. They assist physicians in preventing patient deterioration and hospitalization while keeping the patient at home by assisting them in identifying and mitigating condition worsening.

Cordio Medical

Series A in 2017
Cordio Medical offers to create and deliver game-changing solutions for monitoring health conditions using a patient's voice. They offer transcription of a patient free speech into a smartphone app. They assist physicians in preventing patient deterioration and hospitalization while keeping the patient at home by assisting them in identifying and mitigating condition worsening.

Digma Medical

Series B in 2016
Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGone™ to treat insulin resistance - the underlying mechanism of the disease. The DiaGone™ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Control™ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGone™ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.

Rise.ai

Seed Round in 2016
Rise.ai is a strategic re-engagement solution that provides brands and retailers with a unique currency of their own. Powered by Artificial Intelligence, Rise.ai helps merchants grow by retaining customers and increasing their average spending.

Eve Pharma

Seed Round in 2016
Eve Pharma is a preclinical drug delivery firm that is working to develop medications for the treatment of bacterial vaginosis. The firm focuses in gynecology and provides a product that promises to identify the source of a vaginal infection, allowing clinicians to easily diagnose and treat their patients.

OutSense

Seed Round in 2016
OutSensedevelops an IOT sensor for early detection of illness and as wellness monitoring tool. A medical status report for each person is generated daily in the form of our biological excretions. OutSense is using innovative imaging technologies to reveal this information. The sensor will monitor essential health and wellness parameters and communicate them with a mobile device app. The primary goal is to prevent colorectal cancer by identifying hidden blood in stool. Hidden blood is a well-established screening tool for colorectal cancer (CRC), currently performed by sending a stool sample to a specialized lab.

Magneto Thrombectomy

Seed Round in 2016
Medical device for clot retrival

NeuroApplied

Seed Round in 2016
NeuroApplied offers customer-focused marketing based on the study of the customers’ collective subconscious. The company applies machine-learning analytics, in combination with neural-networks computing, to online picture games in order to provide its clients with useful data collected from the associative subconscious of their customers. Its SaaS-based platform provides an intuitive dashboard for insights that is nonintrusive, and visually stimulating for respondents. NeuroApplied was founded by Lior Moyal, Elhanan Meirovithz, and Inna Schneiderman in June 2016.

Eximo Medical

Series C in 2016
Eximo Medical is an early stage Israeli company with a novel hybrid catheter technology for superior tissue resection invascular and gastrointestinal endoluminal applications. CatHI™, Eximo's proprietary single-use hybrid catheter, combines the best of the two leading technology solutions: optical fibers that deliver short laser pulse and a "blunt" mechanical knife.

Restore Medical Solutions

Seed Round in 2016
Restore Medical Solutions is a medical device company focusing on products and techniques that promote SSI reduction, safety, and productivity within healthcare. The company manufactures a sterilization tray system that reduces the risk of infection from contaminated medical instruments. Its modular sterilization tray systems reduce the potential risk of infection from contaminated instruments and enable surgical departments to improve the quality of care while reducing cost. Founded in 2012, Restore Medical Solutions is headquartered in Memphis, Tennessee.

mPharma

Seed Round in 2016
mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly to consumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices. The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013.

SinuSafe Medical

Seed Round in 2016
SinuSafe Medical develops a nano-debrider device for sinuses irrigating and aspirating without surgical intervention. The device implants bone between the lining and maxillary sinus in the upper jaw, allowing patients to get rid of sinus problems. SinuSafe Medical was founded in 2014 and is headquartered in Tel Aviv, Israel.

mPharma

Seed Round in 2016
mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. It aims to increase patient access to high-quality medications. mPharma partners with drug manufacturers, insurance companies, financial institutions, and governments to deliver prescription drugs directly to consumers in emerging markets. They provide doctors, patients, and pharmacists access to a network of high-quality chronic disease medicine at sustainable prices. The company was founded by Gregory Rockson (CEO), Daniel Shoukimas (CPO), and James Finucane (CTO) in 2013.

Memic Innovative Surgery

Series A in 2015
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Memic Innovative Surgery

Seed Round in 2015
Memic Innovative Surgery develops and delivers robotic surgical solutions designed to enable otherwise infeasible surgical procedures. Its first offering facilitates a variety of robotic gynecological procedures via a vaginal approach, expanding the feasibility of vaginal surgery to the vast majority of cases. Its robotic technology consists of miniature and humanoid-shaped articulated arms that mimic human dexterity while surpassing human flexibility. The robotic arms are controllable via various proprietary control consoles to maintain natural control of the arms, allowing surgeons to operate precisely in tight anatomical spaces with decreased risk to nearby organs and tissue.

Evolero

Seed Round in 2015
Evolero is an event & conference management software that’s a one-stop-platform. It offers all online services and tools for conference planning and organizing. Sell your tickets online, manage your event ticketing and registration, offer your sponsors advanced marketing tools and your attendees powerful networking tools – all in one place. Evolero offers meeting planners and congress organizers the most up-to-date conference management, with a social twist!

Yotta Green

Seed Round in 2014
Yotta is the first-of-its-kind smart home system that enhances energy efficiency and comfort and provides safety services based on household behavior. Yotta's proprietary breakthrough technologies monitor and measure household power consumption and learn consumer usage patterns. Once the system understands the behavioral patterns of the household, it transforms abnormal electrical behavior into useful insights and reacts appropriately: for instance, alerting the consumers to potential energy waste or electrical hazards or fires; turning off lights and appliances that are not in use, or even lowering blinds before an upcoming storm. These services are provided through a user-friendly smart phone app as well as touch and gesture activation devices that allow for maximum convenience and comfort.

Cordio Medical

Seed Round in 2014
Cordio Medical offers to create and deliver game-changing solutions for monitoring health conditions using a patient's voice. They offer transcription of a patient free speech into a smartphone app. They assist physicians in preventing patient deterioration and hospitalization while keeping the patient at home by assisting them in identifying and mitigating condition worsening.

ShapeDo

Pre Seed Round in 2014
ShapeDo develops software that helps manage plan changes in construction projects. The system ensures that plan changes are accounted for in contracts, budgets, and other agreements. ShapeDo's software tracks blueprint versions, compares versions, and facilitates creation of court-ready pricing reports, requests for information (RFIs), and claims. ShapeDo has been involved in major infrastructure projects, such as a new international airport, an underground train, hospitals, and data centers. The system can also be used in smaller commercial and residential projects.

NitiNotes

Seed Round in 2013
Nitinotes has developed the EndoZip™, a fully automated, gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction to help obese patients reduce weight.

Jobrain

Seed Round in 2013
Jobrain - Job Search app - where you can post your resume to a network of recruiters and Machine Learning will determine which is the best fit for you. Jobrain is a Technology of know-how in ever ending job search market based on the latest trends and of course on basics of how to get a job nova days. We created a network of recruiters and targeted more than 100,000 positions, worldwide. Most of them are related to Software development and small start-ups.

Zuznow

Seed Round in 2013
Zuznow’s automatic rapid mobile application development (RMAD) platform is a complete Front-end-as-a-Service (FAAS) that enables large businesses and enterprises to implement a sustainable, successful mobile strategy. The Zuznow platform can be used for B2B, B2C and B2E enterprise applications, serving as a single resource for your mobility needs. Leverage your complex web applications to create premium secured mobile apps, while accelerating time to market and reducing complexity, setup and maintenance costs by more than 90%.

MarketYze

Seed Round in 2012
Marketyze is a technology company that offers semantic site search and online price comparison solutions ground on deep domain expertise. Catering to the retail industry, the company’s pricing intelligence software tracks and analyzes pricing, and market and internal data to discover how pricing events can affect company sales performance. This in turn empowers companies to fine tune their pricing policies to maximize both sales and profits. Marketyze was founded by Onn Manelson and Nave Ronen in December 2011 and is based in Israel.

Evolero

Seed Round in 2012
Evolero is an event & conference management software that’s a one-stop-platform. It offers all online services and tools for conference planning and organizing. Sell your tickets online, manage your event ticketing and registration, offer your sponsors advanced marketing tools and your attendees powerful networking tools – all in one place. Evolero offers meeting planners and congress organizers the most up-to-date conference management, with a social twist!

NLT SPINE

Venture Round in 2012
NLT SPINE, a clinical stage VC-backed company, specializes in the development and marketing of innovative Minimally Invasive Spinal Surgery (MISS) products for treating degenerative spinal conditions. The company's vision is to improve patient care by shifting from traditional open surgical routines to MISS, employing new methods and technologies to enhance safety, predictability and outcomes.

ArTack Medical

Seed Round in 2012
ArTack Medical is a privately held medical device company that develops tools for the invasive surgery market. The tools are based on ArTack Medical's patented drive platform, which allows the delivery of torque through a 5mm shaft. ArTack Medical was founded on 2013 and is headquartered in Haifa, Israel.

Mend

Seed Round in 2011
Mend specializes in open-source software (OSS) lifecycle management solutions, offering a comprehensive cloud-based platform designed to manage the OSS lifecycle effectively. Their flagship product integrates seamlessly with development environments and DevOps pipelines, enabling real-time detection of open-source libraries that may pose security or compliance risks. Mend provides actionable remediation paths to resolve identified issues quickly and enforces automated policies to streamline the fixing process. The platform supports over 200 programming languages and continuously monitors multiple open-source vulnerability databases, ensuring that users are informed of potential risks while minimizing false positives. Founded in 2011 and headquartered in New York, Mend maintains additional offices in Boston, Givatayim, the United Kingdom, and Switzerland.

CartiHeal

Series C in 2011
CartiHeal, a privately held medical device company headquartered in Israel, is a pioneer in the field of cartilage regeneration. Cartilage injuries affect millions of patients around the world, and characteristically cause severe pain and disability. Hyaline cartilage has a very limited ability to heal once damaged. Research indicates that injuries to joint cartilage, if left untreated, may lead to progressive joint changes and early onset of osteoarthritis. The need for a simple, well-tolerated and effective solution for cartilage repair and regeneration represents one of medicine’s most challenging unmet needs. CartiHeal's flagship Agili-C™ implant represents a significant medical breakthrough. This implant has shown to promote regeneration of true hyaline cartilage and its subchondral bone, simultaneously without the use of cells, growth factors or other exogenous agents. The cell-free implant is inserted arthroscopically or via a minimally-invasive approach.

Peak-Dynamics

Seed Round in 2011
Peak-Dynamics is a research-driven hi-tech company that addresses the complexity of operating a water utility, charged with maintaining reliability of service and assuring water quality, while minimizing energy and other operational costs. Its groundbreaking software system, PeakWater, and innovative OSSA (Optimized Stochastic Search Algorithm) technology, offers water utility management and operations personnel means to realize significant energy savings. Starting out in a technological incubator, Peak-Dynamics emerged to become a member of the MER Group with its innovative system, PeakWater, representing a new level of water utility management. Overlooking and interfacing with the SCADA system from which it collects current and historic data, it monitors and controls the energy efficiency aspects of the network's operation. A uniquely new feature introduced by the system involves a comparative analysis of energy supplier tariffs. Ensuring compliance with contractual demands and constraints, PeakWater allows water authorities to take advantage of the increasingly open private energy market. No other available system includes this considerable cost-saving option. Combining optimized water system management with optimized leverage of energy tariffs, Peak-Dynamics seeks to usher utilities to a new level of operations in the era of the Water-Energy Nexus. Marketing its solution to water system management companies and integrators, as well as to municipal, regional and national water authorities, it offers previously unattainable levels of reliability and cost savings. Peak-Dynamics is manned by a team of highly educated and skilled personnel from software developers through seasoned hi-tech entrepreneurs and experts in international sales activities, to renowned business consultants, R&D managers and experts in the field of water system modeling and pricing decisions. Poised for growth, the company has recently established representation in the US.

Eximo Medical

Seed Round in 2011
Eximo Medical is an early stage Israeli company with a novel hybrid catheter technology for superior tissue resection invascular and gastrointestinal endoluminal applications. CatHI™, Eximo's proprietary single-use hybrid catheter, combines the best of the two leading technology solutions: optical fibers that deliver short laser pulse and a "blunt" mechanical knife.

CardioGard Medical

Seed Round in 2011
CardioGard develops a specially designed arterial cannula for the removal of gaseous material during heart bypass surgeries. The system is composed of a double-lumen cannula in which the primary lumen provides oxygenated blood from the heart-lung machine to the patient and a secondary lumen suctions blood and embolic matter away from the surgical field and back to the cardiopulmonary bypass machine for the filtration.

Otic Pharma

Seed Round in 2010
Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com

Quicklizard

Seed Round in 2010
Quicklizard is a leading AI-powered dynamic pricing technology for retailers and brands. It allows retailers & D2C brands to manage their pricing strategies fully on a single platform that provides the tools, insights, and analytics required for business expansion and profit growth. We offer a multi-channel, 100% open platform that enhances businesses across a diverse range of retail industries, including consumer electronics, beauty, home & furniture, sporting goods, apparel, pet supplies, groceries, and airlines. Our platform is deployed in over 40 markets, integrating both online and offline channels and producing hundreds of millions of price recommendations each month.

Rocketick

Seed Round in 2010
Rocketick, founded in 2008 by a group of hardware-assisted-acceleration experts, is a pioneer in GPU-based simulation acceleration for chip verification. Its first product, RocketSimâ„¢, solves functional verification bottlenecks by complementing simulators with a GPU-based acceleration solution that offers 10x faster simulations for highly complex designs. RocketSim is used today by several semiconductor customers.

Valire

Seed Round in 2010
Valire is a software solution company that specializes in the field of artificial intelligence. It features fraud risk assessment, business process validation, and algorithm development that helps businesses, companies, and organizations to secure their revenue. The company was founded in 2009 and headquartered in HaMerkaz, Israel.

CartiHeal

Series A in 2009
CartiHeal, a privately held medical device company headquartered in Israel, is a pioneer in the field of cartilage regeneration. Cartilage injuries affect millions of patients around the world, and characteristically cause severe pain and disability. Hyaline cartilage has a very limited ability to heal once damaged. Research indicates that injuries to joint cartilage, if left untreated, may lead to progressive joint changes and early onset of osteoarthritis. The need for a simple, well-tolerated and effective solution for cartilage repair and regeneration represents one of medicine’s most challenging unmet needs. CartiHeal's flagship Agili-C™ implant represents a significant medical breakthrough. This implant has shown to promote regeneration of true hyaline cartilage and its subchondral bone, simultaneously without the use of cells, growth factors or other exogenous agents. The cell-free implant is inserted arthroscopically or via a minimally-invasive approach.

Cellvine

Seed Round in 2008
Cellvine develops and markets innovative coverage and capacity solutions for the wireless telecommunications industry. Cellvine's broad range of cellular coverage enhancement products and solutions are based on its exclusive technology for improving cellular signals for in-building, urban and rural over-ground and subterranean environments such as mines and tunnels.

CardioNova

Seed Round in 2007
Medical Device to Treat Atrial Fibralation

Valtech Cardio

Seed Round in 2007
Valtech Cardio (Israel) a development-stage medical device company focused on minimally invasive percutaneous annuloplasty ring valve repair for the treatment of mitral valve regurgitation.

Kailight Photonics

Series B in 2006
Kailight Photonics develops optical modules for the telecommunications industry. It offers tunable optical signal regenerator, an optical component that operates with regenerators, optical switches, add/drop multiplexers, and cross-connects. The company's optical transmission, signal regeneration, and wavelength conversion technology provides optical-networking solutions for systems vendors. It provides its products to long-haul network market segments. The company, formerly known as Chilight Technologies, was founded in 2000 and is headquartered in Rehovot, Israel with an additional office in Dallas, Texas. As of May 15, 2007, Kailight Photonics, Inc. operates as a subsidiary of Optium Corporation.

Neovasc

Seed Round in 2006
Neovasc Inc. is a specialty medical device company that develops and manufactures products for the rapidly growing cardiovascular device marketplace.Neovasc Inc. offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners.

Topspin Medical

Series B in 2002
TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size.
VisionCare Ophthalmic Technologies, Inc., a Saratoga, CA-based developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD). VisionCare Ophthalmic Technologies (VisionCare) is a privately held specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. Our lead product, the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), is the first FDA-approved implantable medical device demonstrated to improve vision and quality of life in individuals with the most advanced, irreversible form of age-related macular degeneration (AMD) – End-Stage AMD. End-Stage AMD is the leading cause of blindness in older Americans. The telescope implant is integral to the CentraSight™ treatment program which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care. Our goal is to help patients reconnect to the things in life they love to see and do. To help achieve this, we will establish a high level of collaboration with our healthcare provider customers through a broad range of direct support programs and services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.